198 related articles for article (PubMed ID: 26218133)
1. Curcumin-Mediated HDAC Inhibition Suppresses the DNA Damage Response and Contributes to Increased DNA Damage Sensitivity.
Wang SH; Lin PY; Chiu YC; Huang JS; Kuo YT; Wu JC; Chen CC
PLoS One; 2015; 10(7):e0134110. PubMed ID: 26218133
[TBL] [Abstract][Full Text] [Related]
2. Curcumin suppresses multiple DNA damage response pathways and has potency as a sensitizer to PARP inhibitor.
Ogiwara H; Ui A; Shiotani B; Zou L; Yasui A; Kohno T
Carcinogenesis; 2013 Nov; 34(11):2486-97. PubMed ID: 23825154
[TBL] [Abstract][Full Text] [Related]
3. Dihydrocoumarin, an HDAC Inhibitor, Increases DNA Damage Sensitivity by Inhibiting Rad52.
Chen CC; Huang JS; Wang TH; Kuo CH; Wang CJ; Wang SH; Leu YL
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29215575
[TBL] [Abstract][Full Text] [Related]
4. HDACs link the DNA damage response, processing of double-strand breaks and autophagy.
Robert T; Vanoli F; Chiolo I; Shubassi G; Bernstein KA; Rothstein R; Botrugno OA; Parazzoli D; Oldani A; Minucci S; Foiani M
Nature; 2011 Mar; 471(7336):74-79. PubMed ID: 21368826
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of type I histone deacetylase increases resistance of checkpoint-deficient cells to genotoxic agents through mitotic delay.
Alao JP; Olesch J; Sunnerhagen P
Mol Cancer Ther; 2009 Sep; 8(9):2606-15. PubMed ID: 19723888
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathways: old drugs define new pathways: non-histone acetylation at the crossroads of the DNA damage response and autophagy.
Botrugno OA; Robert T; Vanoli F; Foiani M; Minucci S
Clin Cancer Res; 2012 May; 18(9):2436-42. PubMed ID: 22512979
[TBL] [Abstract][Full Text] [Related]
7. Curcumin-Induced DNA Demethylation in Human Gastric Cancer Cells Is Mediated by the DNA-Damage Response Pathway.
Tong R; Wu X; Liu Y; Liu Y; Zhou J; Jiang X; Zhang L; He X; Ma L
Oxid Med Cell Longev; 2020; 2020():2543504. PubMed ID: 32617134
[TBL] [Abstract][Full Text] [Related]
8. Targeting HR Repair as a Synthetic Lethal Approach to Increase DNA Damage Sensitivity by a RAD52 Inhibitor in BRCA2-Deficient Cancer Cells.
Tseng WC; Chen CY; Chern CY; Wang CA; Lee WC; Chi YC; Cheng SF; Kuo YT; Chiu YC; Tseng ST; Lin PY; Liou SJ; Li YC; Chen CC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922657
[TBL] [Abstract][Full Text] [Related]
9. HDAC turnover, CtIP acetylation and dysregulated DNA damage signaling in colon cancer cells treated with sulforaphane and related dietary isothiocyanates.
Rajendran P; Kidane AI; Yu TW; Dashwood WM; Bisson WH; Löhr CV; Ho E; Williams DE; Dashwood RH
Epigenetics; 2013 Jun; 8(6):612-23. PubMed ID: 23770684
[TBL] [Abstract][Full Text] [Related]
10. A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I.
Yu CC; Pan SL; Chao SW; Liu SP; Hsu JL; Yang YC; Li TK; Huang WJ; Guh JH
Biochem Pharmacol; 2014 Aug; 90(3):320-30. PubMed ID: 24915421
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Histone Deacetylase Activity in Malignant Melanoma Provokes RAD51 and FANCD2-Triggered Drug Resistance.
Krumm A; Barckhausen C; Kücük P; Tomaszowski KH; Loquai C; Fahrer J; Krämer OH; Kaina B; Roos WP
Cancer Res; 2016 May; 76(10):3067-77. PubMed ID: 26980768
[TBL] [Abstract][Full Text] [Related]
12. HDAC inhibitors: roles of DNA damage and repair.
Robert C; Rassool FV
Adv Cancer Res; 2012; 116():87-129. PubMed ID: 23088869
[TBL] [Abstract][Full Text] [Related]
13. Histone Deacetylase Inhibitors as Anticancer Drugs.
Eckschlager T; Plch J; Stiborova M; Hrabeta J
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671573
[TBL] [Abstract][Full Text] [Related]
14. Chromosome-wide histone deacetylation by sirtuins prevents hyperactivation of DNA damage-induced signaling upon replicative stress.
Simoneau A; Ricard É; Weber S; Hammond-Martel I; Wong LH; Sellam A; Giaever G; Nislow C; Raymond M; Wurtele H
Nucleic Acids Res; 2016 Apr; 44(6):2706-26. PubMed ID: 26748095
[TBL] [Abstract][Full Text] [Related]
15. Preclinical anti-myeloma activity of EDO-S101, a new bendamustine-derived molecule with added HDACi activity, through potent DNA damage induction and impairment of DNA repair.
López-Iglesias AA; Herrero AB; Chesi M; San-Segundo L; González-Méndez L; Hernández-García S; Misiewicz-Krzeminska I; Quwaider D; Martín-Sánchez M; Primo D; Paíno T; Bergsagel PL; Mehrling T; González-Díaz M; San-Miguel JF; Mateos MV; Gutiérrez NC; Garayoa M; Ocio EM
J Hematol Oncol; 2017 Jun; 10(1):127. PubMed ID: 28633670
[TBL] [Abstract][Full Text] [Related]
16. Delineation of the role of chromatin assembly and the Rtt101Mms1 E3 ubiquitin ligase in DNA damage checkpoint recovery in budding yeast.
Diao LT; Chen CC; Dennehey B; Pal S; Wang P; Shen ZJ; Deem A; Tyler JK
PLoS One; 2017; 12(7):e0180556. PubMed ID: 28749957
[TBL] [Abstract][Full Text] [Related]
17. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species.
Kang J; Chen J; Shi Y; Jia J; Zhang Y
Biochem Pharmacol; 2005 Apr; 69(8):1205-13. PubMed ID: 15794941
[TBL] [Abstract][Full Text] [Related]
18. Disparity of histone deacetylase inhibition on repair of radiation-induced DNA damage on euchromatin and constitutive heterochromatin compartments.
Karagiannis TC; Harikrishnan KN; El-Osta A
Oncogene; 2007 Jun; 26(27):3963-71. PubMed ID: 17213813
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis.
Chung YL; Lee MY; Pui NN
Carcinogenesis; 2009 Aug; 30(8):1387-97. PubMed ID: 19351790
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Ahrens TD; Timme S; Hoeppner J; Ostendorp J; Hembach S; Follo M; Hopt UT; Werner M; Busch H; Boerries M; Lassmann S
Epigenetics; 2015; 10(5):431-45. PubMed ID: 25923331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
